China to Offer COVID-19 Vaccine for $ 60 in Jiaxing City

Jiaxing City in China will be the first to sell the COVID-19 vaccine, which will be available for just $ 60.

The race against Covid-19 continues to show advances in the field of medicine, as in recent weeks countries like the US and Russia have unveiled their vaccines to eradicate and prevent the virus from spreading.

China wasn’t far behind either when it launched its vaccine called “CoronaVac” to compete with the aforementioned countries, and it was announced that it was selling the vaccine in Jiaxing City at a cost of just US $ 60 – dollars will be yours.

For the past few hours, that fact has been at the top of today’s news as the Covid-19 vaccine has become the new weapon for economic competition between world powers.

China sells Covid-19 vaccine for $ 60

The authorities at the Jiaxing City Health Department in eastern Zhejiang Province announced that they will put their Covid-19 vaccine on sale this Friday, October 16.

The vaccine was made by the pharmaceutical company Sinovac Biotech and costs approximately $ 60 to be purchased by key workers and at risk groups. This is a considerably low price.

It was also announced that Coronavac is being offered for sale at the Center for Disease Control and Prevention for 200 yuan (about US $ 30) and is already being used by doctors and other key groups.

China is trying to conquer the Covid-19 market

As we told you in La Verdad Noticias, Russia has announced its second vaccine and the preparation of the third. China is therefore trying to position itself as the first country to produce the vaccine against Covid-19 on a large scale.

To this end, agreements have been made with other Asian and even Latin American countries that are participating in clinical studies and have already “pre-ordered” millions of doses of the “CoronaVac” developed by China.

These were the details of the news China to Offer COVID-19 Vaccine for $ 60 in Jiaxing City for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at de24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT Why is “long-term Covid” a bigger problem than we think?